TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 183.8M
Gross Profit 31.1M 16.90%
Operating Income 14.8M 8.06%
Net Income 13.5M 7.33%
EPS (Diluted) $0.80

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 420.7M
Shareholders Equity 759.0M
Debt to Equity 0.55

Cash Flow Metrics

Operating Cash Flow 8.0M
Free Cash Flow -7.3M

Revenue & Profitability Trend

U.S. Physical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i671.3M604.8M553.1M495.0M423.0M
Cost of Goods Sold i547.4M483.3M441.1M377.8M328.5M
Gross Profit i123.9M121.5M112.0M117.2M94.4M
Gross Margin % i18.5%20.1%20.3%23.7%22.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i--46.1M46.5M42.0M
Other Operating Expenses i58.3M51.5M46.1M41.9M28.5M
Total Operating Expenses i58.3M51.5M92.2M88.5M70.6M
Operating Income i65.6M70.0M65.9M75.2M65.9M
Operating Margin % i9.8%11.6%11.9%15.2%15.6%
Non-Operating Items
Interest Income i3.9M3.8M00142.0K
Interest Expense i8.0M9.3M5.8M942.0K1.6M
Other Non-Operating Income-1.3M-15.1M-4.6M-1.1M1.1M
Pre-tax Income i60.2M49.4M55.6M73.2M65.5M
Income Tax i14.6M12.2M12.2M15.3M13.0M
Effective Tax Rate % i24.3%24.6%21.9%20.9%19.9%
Net Income i45.6M37.2M43.4M57.9M52.5M
Net Margin % i6.8%6.2%7.8%11.7%12.4%
Key Metrics
EBITDA i89.6M90.8M82.7M88.4M76.6M
EPS (Basic) i$1.84$1.28$2.25$2.41$2.48
EPS (Diluted) i$1.84$1.28$2.25$2.41$2.48
Basic Shares Outstanding i1506400014188000129850001289800012835000
Diluted Shares Outstanding i1506400014188000129850001289800012835000

Income Statement Trend

U.S. Physical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i41.4M152.8M31.6M28.6M32.9M
Short-term Investments i-----
Accounts Receivable i59.0M69.7M68.6M46.3M41.9M
Inventory i-----
Other Current Assets10.6M10.8M11.1M4.2M3.8M
Total Current Assets i137.6M233.4M111.3M95.2M87.6M
Non-Current Assets
Property, Plant & Equipment i133.9M103.4M103.0M96.4M81.6M
Goodwill i1.5B1.1B1.1B955.7M747.6M
Intangible Assets i179.3M109.7M108.8M86.4M56.3M
Long-term Investments-----
Other Non-Current Assets5.2M2.8M4.1M1.6M1.5M
Total Non-Current Assets i1.0B763.9M746.9M654.3M506.7M
Total Assets i1.2B997.2M858.2M749.4M594.4M
Liabilities
Current Liabilities
Accounts Payable i5.9M3.9M6.5M6.5M1.3M
Short-term Debt i50.8M42.9M41.6M31.3M32.4M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i116.3M102.2M85.5M83.5M93.5M
Non-Current Liabilities
Long-term Debt i244.4M215.6M253.8M191.8M78.6M
Deferred Tax Liabilities i29.5M24.8M21.3M14.4M7.8M
Other Non-Current Liabilities18.3M2.4M13.0M7.3M4.5M
Total Non-Current Liabilities i292.1M242.8M288.1M213.5M90.9M
Total Liabilities i408.4M345.0M373.6M297.0M184.4M
Equity
Common Stock i172.0K172.0K152.0K151.0K151.0K
Retained Earnings i227.3M223.8M232.9M224.4M212.0M
Treasury Stock i31.6M31.6M31.6M31.6M31.6M
Other Equity-----
Total Shareholders Equity i759.0M652.2M484.6M452.4M410.0M
Key Metrics
Total Debt i295.2M258.6M295.3M223.1M111.0M
Working Capital i21.3M131.2M25.8M11.7M-5.9M

Balance Sheet Composition

U.S. Physical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i45.6M37.2M43.4M57.9M52.5M
Depreciation & Amortization i18.7M15.7M14.7M11.6M10.5M
Stock-Based Compensation i7.8M7.2M7.3M7.9M7.9M
Working Capital Changes i-14.1M-4.9M-14.0M-16.4M15.7M
Operating Cash Flow i64.1M59.1M53.4M66.6M86.7M
Investing Activities
Capital Expenditures i-9.2M-9.3M-8.2M-8.2M-7.6M
Acquisitions i-142.0M-36.9M-74.3M-116.1M-43.6M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-150.5M-45.8M-82.5M-124.3M-51.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-26.5M-24.1M-21.3M-18.8M-4.1M
Debt Issuance i19.0M24.0M251.0M316.0M214.0M
Debt Repayment i-14.7M-63.2M-186.8M-222.9M-245.0M
Financing Cash Flow i-37.0M84.3M25.8M141.4M-69.4M
Free Cash Flow i65.8M72.7M50.3M68.2M92.4M
Net Change in Cash i-123.4M97.5M-3.3M83.6M-34.0M

Cash Flow Trend

U.S. Physical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 37.46
Forward P/E 29.58
Price to Book 2.60
Price to Sales 1.81
PEG Ratio 1.60

Profitability Ratios

Profit Margin 5.28%
Operating Margin 12.40%
Return on Equity 7.45%
Return on Assets 4.24%

Financial Health

Current Ratio 1.18
Debt to Equity 39.89
Beta 1.45

Per Share Data

EPS (TTM) $2.29
Book Value per Share $32.94
Revenue per Share $47.75

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
usph1.3B37.462.607.45%5.28%39.89
HCA Healthcare 94.2B16.91-76.8113,631.68%8.21%-37.45
Tenet Healthcare 15.7B11.184.2029.65%7.18%158.70
Acadia Healthcare 1.9B13.800.624.83%4.31%74.74
Select Medical 1.8B23.211.077.72%3.33%136.22
Pacs 1.8B19.413.15110.96%2.59%469.36

Financial data is updated regularly. All figures are in the company's reporting currency.